Advertisement

Topics

SanBio Company Limited Company Profile

06:12 EDT 26th June 2019 | BioPortfolio


News Articles [209 Associated News Articles listed on BioPortfolio]

SanBio: Addition of a Cerebral Hemorrhage Program for SB623 Regenerative Cell Medicine

At a meeting held today, the Board of Directors of SanBio Co., Ltd. (hereinafter, the “Company”) resolved to add a program for treatment of chronic motor deficit from cerebral...

VINTAGE PEN PIERRE CARDIN SIGMA – ALDRICH ADVERTISING LIMITED PRESENTATION BOX

EUR 7.31 (0 Bids)End Date: Wednesday Jun-19-2019 23:33:29 ISTBid now | Add to watch list Biotech365 : VINTAGE PEN PIERRE CARDIN SIGMA – ALDRICH ADVERTISING LIMITED PRESENTATION BOX BioMarke...

Tauriga Sciences, Inc. Incorporates Private Limited Company in Belfast, Northern Ireland

NEW YORK, NY, June 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through t...

Quotient Limited Announces Receipt of Consents to Modifications to the Company’s Senior Secured Notes

JERSEY, Channel Islands, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the receipt of consents from the ho...

Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference

JERSEY, Channel Islands, March 07, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Ch...

SanBio’s SB623 meets in Phase II for TBI

SanBio to Announce the Results of a Phase 2 STEMTRA Trial Regarding the Use of Regenerative Cell Medicine SB623 as a Treatment for TBI at an Annual Scientific Meeting of the American Association of Neurological Surgeons

The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.) (TOKYO: 4592), a scientific leader in regenerative medicine for neurological disorders, today announced its plan to make publi...

Management tracks: Biogen’s McKenzie departing for CSL; plus Rubius, SanBio, Avita and more

Drugs and Medications [384 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [support medical company]

Oxygen

Oxygen [island equipment company]

Oxygen

Oxygen [lowry drug company inc. ]

Oxygen

Heparin sodium [cantrell drug company]

Heparin Sodium 25,000 USP Units Added to 0.45% Sodium Chloride 250 mL Bag

Labetalol hcl [cantrell drug company]

Labetalol HCl 5 mg/mL 4 mL Syringe

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Effects of Insufflated Gas on Core Temperature and Post-operative Pain During Laparoscopic Surgery

During laparoscopy, administration of cold and dry carbon dioxide (CO2) leads to hypothermia. Different types of gas conditioning have been studied in order to prevent this specific hypoth...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Companies [1575 Associated Companies listed on BioPortfolio]

SanBio, Inc.

SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is be...

SanBio Group

SanBio is a regenerative medicine company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research, development and clinical tr...

SanBio Company Limited

SanBio Co., Ltd.

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "SanBio Company Limited" on BioPortfolio

We have published hundreds of SanBio Company Limited news stories on BioPortfolio along with dozens of SanBio Company Limited Clinical Trials and PubMed Articles about SanBio Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SanBio Company Limited Companies in our database. You can also find out about relevant SanBio Company Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record